1. J. H. Kim, S. J. Sin. “Medical Technology Reassessment Report: Vitamin D Test”.National Evidence-based Healthcare Collaborating Agency, (2021).

2. I. K. Jung. “Association between High-Density Lipoprotein Cholesterol and Vitamin D Levels in Adult Men in the Fifth Korea National Health and Nutrition

Examination Survey”. Korean Journal of Health Promotion, Vol.19, No.4 pp. 210-220, (2019).

3. Vitezova, A., Zillikens, M. C., Van Herpt, T. T. W., Sijbrands, E. J. G., Hofman, A., Uitterlinden, A. G, Kiefte-de Jong, J.,“Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study”, European Journal of Endocrinology, Vol.172, No.3, pp. 327-335, (2015).

4. H. R. Yoon, H. S. Kwak, E. H, Nah, C. H. Cho, “Associations between Vitamin Dand Indicators of Common Chronic Diseases in Korean Adults”, Laboratory

Medicine Online, Vol.13, No.3, pp. 223-229, (2023).

5. The Korean Society of Lipid and Atherosclerosis [Ienternet]. https://www.lipid.or.kr/reference/factsheets.php?mode=view&idx=1266. (accessed May., 10, 2025)

6. Korea Disease Control and Prevention Agency[Ienternet]. Presentation of the 2023 Results from the Second Year of the 9th Korea National Health and Nutrition

Examination Survey (KNHANES),https://knhanes.kdca.go.kr/knhanes/archive/wsiRsltPrsntnData.do.(accessed May., 10, 2025)

7. Anagnostis, P., Bitzer, J., Cano, A., Ceausu, I., Chedraui, P., Durmusoglu, F., Rees, M., “Menopause symptom managementin women with dyslipidemias: an EMAS clinical guide”, Maturitas, Vol.135, pp. 82-88,(2020).

8. I. S. Jeong, H. S. Yun, M. S. Kim, Y. S. Hwang, “Incidence and risk factors ofdyslipidemia after menopause”, Journal of Korean Academy of Nursing, Vol.52, No.2, pp. 214-227, (2022).

9. Korea Disease Control and Prevention Agency[Ienternet]. Korea Centers forDisease Control and Prevention (2023) The 9th Korean National Health and Nutrition Examination Survey (KNHANES Ⅸ-1),https://knhanes.kdca.go.kr. (accessed May.,10, 2025)

10. J. Park, Y. Choi, S. Cho, H. Park, S. Kim, H. I. Cho, E. H. Nah, “Vitamin DStatus and Reference Intervals Measured by Liquid Chromatography–Tandem Mass

Spectrometry for the Early Adulthood to Geriatric Ages in a South KoreanPopulation during 2017–2022”, Nutrients, Vol.16, No.5, pp. 604, (2024).

11. M. G. Shin, K. H. Yoon, M. Y. Song, “Comparison of Health Behaviors andNutritional Status related to Dyslipidemia in Korean Middle-Aged Adults-From the

Korean National Health and Nutrition Examination Surveys, 2007~ 2010”, TheKorean Journal of Food And Nutrition, Vol.29, No.5, pp. 724-734. (2016).

12. M. Y. Shin, I. S. Kwun, “Vitamin D: hormone-like nutrient”, Journal ofNutrition and Health, Vol.49, No.1, pp.1-7.(2016).

13. Holick M. F., “Vitamin D status: measurement, interpretation, and clinicalapplication”, Ann Epidemiol, Vol.19, No.2, pp. 73-78, (2009).

14. Holick M. F., Binkley N. C., Bischoff-Ferrari H. A., Gordon C. M.,Hanley D. A., Heaney R. P.,Weaver, C. M., “Evaluation, treatment, and prevention

of vitamin D deficiency: an Endocrine Society clinical practice guideline”, TheJournal of clinical endocrinology & metabolism, Vol.96, No.7, pp. 1911-1930,

(2011).

15. The Korean Society of Lipid and Atherosclerosis [Ienternet]. https://www.lipid.or.kr/dyslipidemia_arteriosclerosis/dyslipidemia_in_koreans2.php. (accessed May., 10, 2025)

16. J. H. Noh, “Vitamin D and Fat Mass”, Korean Journal of Obesity, Vol.25, No.2,pp. 66-67, (2016).

17. Chowdhury, R., Stevens, S., Ward, H., Chowdhury, S., Sajjad, A., Franco, O. H., “Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis”, European journal of epidemiology, Vol.27, pp. 581-591, (2012).

18. C. H, Jong, J. O. Mok, “Vitamin D and Obesity”, Korean Journal of Obesity, Vol.23, No.4, PP, (2014).

19. Abrahamsen B., Masud T., Avenell A., Anderson F., Meyer H. E., Cooper C.,Smith H., LaCroix A. Z., Torgerson D., Johansen A., Jackson R., Rejnmark L.,

Wactawski-Wende J., Brixen K., Mosekilde L., Robbins J. A., Francis R. M.,“DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group.

Patient level pooled analysis of 68 500 patients from seven major vitamin Dfracture trials in US and Europe”, BMJ, Vol. 340, pp. b5463, (2010).

20. Sarmiento-Rubiano, L. A., Angarita Ruidiaz, J. A., Suarez Dávila, H. F., Suarez Rodríguez, A., Rebolledo-Cobos, R. C., & Becerra, J. E., “Relationship between

serum vitamin D levels and HDL cholesterol in postmenopausal women fromColombian Caribbean”, Journal of nutrition and metabolism, Vol.2018, No.1, pp. 9638317. (2018).

21. Riggs, K. A., & Rohatgi, A., “HDL and reverse cholesterol transport biomarkers”, Methodist DeBakey cardiovascular journal, Vol.15, No.1, pp. 39, (2019).

22. Kardassis D., Gafencu A., Zannis V. I., Davalos A., “Regulation of HDL genes:transcriptional, posttranscriptional, and posttranslational”, High Density

Lipoproteins: From Biological Understandingto Clinical Exploitation, pp. 113-179,(2015).

23. Ali, K. M., Wonnerth, A., Huber, K., Wojta, J., “Cardiovascular disease riskreduction by raising HDL cholesterol– current therapies and future opportunities”,

 

 

British journal of pharmacology, Vo/.167, No(6), pp. 1177-1194, (2012).